Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

Humana Inc.’s stock was up 2% Friday after three straight sessions of declines, but investors paying attention to the performance of its bonds on Thursday may have had something of a heads-up on ...

The lower rating won’t affect Humana’s performance until 2026, ... Humana’s logo at the New York Stock Exchange on Dec. 6, when the company traded at close to $500 a share.

Humana’s stock was headed for another sharp selloff on Tuesday, toward a more than four-year low, after the government cut its rating on one of the health insurer’s large Medicare Advantage ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Humana and S&P 500 Performance During 2007-08 Crisis HUM stock declined from $71 in September 2007 (pre-crisis peak) to $24 in March 2009 (as the markets bottomed out).

This stock's P/B looks attractive against its industry's average P/B of 2.20. Within the past 52 weeks, HUM's P/B has been as high as 2.91 and as low as 1.52, with a median of 1.93. Value ...